POMC and adenoma: Conceivably, this may reflect potential differences in study populations, a small sample size, local AVS protocols, underlying molecular pathogenesis of aldosterone‐producing adenomas and heterogeneity of aldosterone secretory response of aldosterone‐producing adenomas to varying doses of ACTH [29].